Neuren shares rocket on Pitt Hopkins trial results publication
ADELAIDE: Neuren Pharmaceuticals’ phase two clinical trial of its drug to treat Pitt Hopkins syndrome
ADELAIDE: Neuren Pharmaceuticals’ phase two clinical trial of its drug to treat Pitt Hopkins syndrome